Skip to main content
. 2009 Sep 28;284(48):33151–33160. doi: 10.1074/jbc.M109.034975

TABLE 2.

Oligonucleotides used in this study

Oligonucleotide Sequence (5′ to 3′)
SifA1F GGGGACAAGTTTGTACAAAAAAGCAGGCTTCGAAGGAGATGCCACCATGAAACATCACCATCACCATCACCCGATTACTATAGGGAATGG
SifA327R GGGGACCACTTTGTACAAGAAAGCTGGGTTTATTATTGTTCTGAGCGAACGTG
SKIP771F GGGGACAAGTTTGTACAAAAAAGCAGGCTTCGAAGGAGATGCCACCATGAAACATCACCATCACCATCACACCATCACCAAAGAAGGCATG
SKIP878R GGGGACCACTTTGTACAAGAAAGCTGGGTTTATCAGGGGATGACCCCTTTGG
SifA1F2 GGGGACAAGTTTGTACAAAAAAGCAGGCTTCGAAGGAGATGCCACCATGAAACATCACCATCACCATCACCCGATCACAATAGGGAATGG
SifA327R2 GGGGACCACTTTGTACAAGAAAGCTGGGTTTATTATAAAAAACCCCTAATCTG
O-201 AAAAAAGAATTCCACCATGCCGATTACTATAGGGAATGG
O-202 AAAAAACCCGGGCTAAAAAACAACATAAACAGCCGC
O-203 CGGATATATTCGCATGGTG
O-276 AAAAGAATTCTCCCATTGAGTGTTGGACAGGG
O-277 AAACAGCTGTTAGTCGCCAAAAAATACCAGTCTGG
O-299 GGGGACAAGTTTGTACAAAAAAGCAGGCTTCCCGATTACTATAGGGAATGGT
O-300 GGGGACCACTTTGTACAAAGCTGGGTCCTATATAAAAAACAACATAAACAGCCGC
O-337 GGGGACCACTTTGTACAAGAAAGCTGGGTCCTACGATTTTAAAATATCCGGGCG
O-338 GGGGACAAGTTTGTACAAAAAAGCAGGCTTCCCGATTACTATAGGGAATGGTTTT
O-343 GGGGACAAGTTTGTACAAAAAAGCAGGCTTCCATCCACAAATGACGGCC
O-344 GGGGACCACTTTGTACAAGAAAGCTGGGTCCTAGCCGCTTTGTTGTTCTGA
O-419 TCATTGGATCCCGCGATTTTAAAATATCCGGGCGATC
O-420 AAAAAAGAATTCCACCATGGACTTCTTTTTTTCTACT
O-421 AAAAAAGAATTCCACCATGGAGTTGAAAGAGTTAGCCTG
O-422 AAAAAAGAATTCCACCATGGAGAACGAATTGTTACGTATC
O-426 TGCTTTTGGATCCCGAAAAAAGAAGTCTTTAATTTTTTC
O-427 TGCGATGGATCCCGTAACTCTTTCAACTCAAAAAAAATC
O-429 TAACAATGGATCCCGTTCGTTTTGATCCATGATGCGAAG
HHS Vulnerability Disclosure